| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Division of Surgical Oncology (IP, DRK, DLD, WGK, JFG) and Division of Radiation Medicine (RJL, GP, CJ), Roswell Park Cancer Institute, State University of New York, Buffalo, New York.
Correspondence: Address correspondence and reprint requests to: John F. Gibbs, MD, Division of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263; Fax: 716-845-3434; E-mail: john.gibbs{at}roswellpark.org
Background: The risk and outcome of regional failure after elective and therapeutic lymph node dissection (ELND/TLND) for microscopically and macroscopically involved lymph nodes without adjuvant radiotherapy were evaluated.
Methods: Retrospective melanoma database review of 338 patients (ELND 85, TLND 253) from 1970 to 1996 with pathologically involved lymph nodes.
Results: Regional recurrence occurred in 14% of patients treated with ELND (n = 12) and 28% of patients treated with TLND (n = 72; P = .009). Risk factors associated with nodal recurrence were advanced age, primary lesion in the head and neck region, depth of the primary lesion, number of involved lymph nodes, and extracapsular extension (ECE). For each nodal basin, the ELND group had a lower incidence of recurrence than the TLND group. The TLND group had larger lymph nodes, greater number of involved lymph nodes, and a higher incidence of ECE. The 10-year disease-specific survival was 51% vs. 30% for ELND and TLND, respectively (P = .0005). Nodal basin failure was predictive of distant metastasis, with 87% developing distant disease compared with 54% of patients without nodal recurrence (P < .0001). Of six patients who underwent a second dissection after isolated nodal recurrence, five patients have had a median disease-free interval of 79 months.
Conclusions: After ELND or TLND, patients who have a large tumor burden (thick primary melanoma, multiply involved lymph nodes, ECE), advanced age, and a primary lesion located in the head and neck have a significantly increased likelihood of relapse and a decreased survival. Few patients present with an isolated nodal recurrence, but the majority can be salvaged by a second dissection.
Key Words: Melanoma • Lymph node dissection • Nodal recurrence.
This article has been cited by other articles:
 |
|
 |
|
  A. B. Francken, N. A. Accortt, H. M. Shaw, M. Wiener, S.-j. Soong, H. J. Hoekstra, and J. F. Thompson Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma Ann. Surg. Oncol., May 1, 2008; 15(5): 1476 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. R. Yurkovetsky, J. M. Kirkwood, H. D. Edington, A. M. Marrangoni, L. Velikokhatnaya, M. T. Winans, E. Gorelik, and A. E. Lokshin Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-{alpha}2b Clin. Cancer Res., April 15, 2007; 13(8): 2422 - 2428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Badruddoja Patterns of Recurrence in Patients With Melanoma After Radical Lymph Node Dissection Arch Surg, November 1, 2006; 141(11): 1145 - 1145. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Wong, D. L. Morton, J. F. Thompson, J. E. Gershenwald, S. P. L. Leong, D. S. Reintgen, H. Gutman, M. S. Sabel, G. W. Carlson, K. M. McMasters, et al. Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study Ann. Surg. Oncol., June 1, 2006; 13(6): 809 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nathansohn, J. Schachter, and H. Gutman Patterns of Recurrence in Patients With Melanoma After Radical Lymph Node Dissection Arch Surg, December 1, 2005; 140(12): 1172 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Pawlik, M. I. Ross, and J. E. Gershenwald Lymphatic Mapping in the Molecular Era Ann. Surg. Oncol., April 1, 2004; 11(4): 362 - 374. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
